Literature DB >> 8389672

Overexpression of oncoproteins in non-small cell lung carcinomas of smokers.

W Wodrich1, M Volm.   

Abstract

Non-small cell lung carcinoma specimens of 173 previously untreated patients were analyzed for the expression of proteins encoded by the oncogenes c-myc, c-fos, c-jun, c-erbB-1, c-erbB-2, c-H-ras, c-K-ras and c-N-ras. Forty-six per cent of the tumors were positive for the c-MYC protein, 60% for c-FOS, 50% for c-JUN, 80% for c-ERBB-1, 55% for c-ERBB-2, 12% for c-H-RAS, 5% for c-K-RAS and 71% for c-N-RAS. Proteins encoded by c-fos and c-jun are overexpressed more frequently in carcinomas of smokers (c-fos: P < 0.005; c-jun: P < 0.01). When we grouped the patients according to their tumor histology the results became more evident. Squamous cell lung carcinomas of smokers showed a higher incidence of c-FOS (P = 0.01), c-JUN (P < 0.01) and c-ERBB-1 (P = 0.01) proteins than squamous cell lung carcinomas of non-smokers. The expression rate and the intensity of staining proved not to be influenced either by the number of cigarettes smoked daily or by cessation of smoking. In adenocarcinomas, however, we only found a trend for a more frequent overexpression of c-fos (P = 0.07) and c-jun (P = 0.14) encoded proteins in carcinomas of smokers and no correlation between the expression of c-erbB-1 products and smoking. No correlation was found between the expression of c-MYC, c-ERBB-2, c-H-RAS, c-K-RAS and c-N-RAS proteins and the smoking habits of the patients, neither in squamous cell carcinomas nor in adenocarcinomas of the lung.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389672     DOI: 10.1093/carcin/14.6.1121

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  12 in total

Review 1.  Role of transcription factors in inflammatory lung diseases.

Authors:  I Rahman; W MacNee
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

2.  Targeted deletion of Jun/AP-1 in alveolar epithelial cells causes progressive emphysema and worsens cigarette smoke-induced lung inflammation.

Authors:  Narsa M Reddy; Suryanaraya Vegiraju; Ashley Irving; Bogdan C Paun; Irina G Luzina; Sergei P Atamas; Shyam Biswal; Navas-Acien Ana; Wayne Mitzner; Sekhar P Reddy
Journal:  Am J Pathol       Date:  2012-02       Impact factor: 4.307

Review 3.  Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis.

Authors:  S Wasswa-Kintu; W Q Gan; S F P Man; P D Pare; D D Sin
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

4.  A dominant-negative c-jun mutant inhibits lung carcinogenesis in mice.

Authors:  Jay W Tichelaar; Ying Yan; Qing Tan; Yian Wang; Richard D Estensen; Matthew R Young; Nancy H Colburn; Hulian Yin; Colleen Goodin; Marshall W Anderson; Ming You
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-17

5.  Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas.

Authors:  M Volm; P Drings; W Wodrich
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

6.  Analysis of c-fos, c-jun, c-erbB1, c-erbB2 and c-myc in primary lung carcinomas and their lymph node metastases.

Authors:  M Volm; G van Kaick; J Mattern
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

7.  Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p.

Authors:  I Petersen; H Langreck; G Wolf; A Schwendel; R Psille; P Vogt; M B Reichel; T Ried; M Dietel
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cells.

Authors:  J Kikuchi; I Kinoshita; Y Shimizu; S Oizumi; M Nishimura; M J Birrer; H Dosaka-Akita
Journal:  Br J Cancer       Date:  2008-11-18       Impact factor: 7.640

9.  Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant.

Authors:  Y Shimizu; I Kinoshita; J Kikuchi; K Yamazaki; M Nishimura; M J Birrer; H Dosaka-Akita
Journal:  Br J Cancer       Date:  2008-02-19       Impact factor: 7.640

10.  The A Allele at rs13419896 of EPAS1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer.

Authors:  Andika C Putra; Hidetaka Eguchi; Kian Leong Lee; Yuko Yamane; Ewita Gustine; Takeshi Isobe; Masahiko Nishiyama; Keiko Hiyama; Lorenz Poellinger; Keiji Tanimoto
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.